Report Highlights
- The global market for protein drugs is expected to increase from an estimated $1.1 billion in 2008 to $1.3 billion in 2013, a compound annual growth rate (CAGR) of 2.9%.
- Amino acids used as flavorants generated an estimated $510.4 million in 2008. This segment should reach $588.2 million in 2013, for a CAGR of 2.9%.
- The animal feeds segment was worth $472.4 million in 2008. This is expected to reach $526.4 million in 2013, for a CAGR of 2.2%.
INTRODUCTION
STUDY OBJECTIVES
This technical/marketing report updates a previous BCC Research study on commercial essential amino acids. Further, this study examines the current state of the commercial essential amino acid business, and presents an in-depth analysis that forecasts and tracks significant changes in the marketplace and identifies those amino acids with current or potentially greater commercial significance.
REASONS FOR DOING THIS STUDY
Commercial interest in amino acids is an outgrowth of an understanding of the many functions that these life-giving substances perform in humans and animals. As understanding of the functions and properties of amino acids increases, new commercial applications enter development, while current commercial uses continue to expand their markets on a worldwide basis. New production technology continues to make large-scale production of these products more economical. In turn, increased availability creates newer and larger markets for these vital substances.
Amino acids gained commercial significance shortly after the turn of the century with the discovery of the flavor-enhancing quality of glutamic acid and the marketing of monosodium glutamate in Japan. Increased knowledge of the role amino acids play in the value of nutritional protein led to their being used to fortify animal feeds, as food supplements for humans, and to sustain seriously ill patients who had to be fed with intravenous solutions.
Since the 20 protein amino acids can be arranged in any order to make any number of polypeptides, their potential for a variety of inventions in the field of medicine is extraordinary. Their current uses in animal feed and food additives will continue to grow as there are no substitutes for amino acids and their value has been well proven.
INTENDED AUDIENCE
This comprehensive study provides facts, data, and insights to senior market and planning executives, venture capitalists and for the amino acid product interest community. It will assist manufacturers of products in any of the applicable markets, as well as technical personnel involved in research and development of production technology for commercial amino acids. This especially includes readers in:
- The chemical industry
- Research institutions involved with studying amino acids
- Amino acid manufacturing
- Industries that have amino acid byproducts
Report Highlights
-
The U.S. amino acid market will likely surpass $1.5 billion by 2005. Annual growth should be 3.3% on average per year (AAGR) while individual amino acids could see growth spurts.
-
With anticipated 2005 U.S. annual sales exceeding $900 million, the animal feed supplements market will remain the largest market category for amino acids.
-
The four amino acids used as food flavoring agents will account for more than $450 million in 2005.
-
Sales of specialty amino acids used for feeding solutions, pharmaceuticals, biotechnology and medical applications, are expected to rise at an AAGR of 6.5% to about $150 million in 2005.
Report Highlights
-
Twenty amino acids go into making up the commercial amino acid market. This group plays many roles in a variety of fields including foods, animal feeds, cosmetics, medicines, and biotechnology as well as some industrial applications. In dollar terms, the most important current uses are in the animal feed industries and human food uses.
-
The three primary categories of commercial amino acids in the U.S. represented a billion-dollar market for the first time in 1999. The U.S. amino acid market should again surpass the billion-dollar mark in 2000 as factories across the nation and around the world increase production and sales to meet a growing demand. The U.S. amino acid market will likely surpass $1.5 billion by 2005.
-
With anticipated 2000 U.S. annual sales exceeding $800 million, the animal feed supplements market represents the largest market category for amino acids. Export sales of amino acid animal feed supplements will exceed $250 million.
Related Reports
Recent Reports
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
3D Cell Cultures: Technologies and Global Markets
The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More